Quantum Genomics S.A.
$0.07▲ 0.00%(+$0.00)
TickerSpark Score
30/100
▌ Poor
40
Valuation
20
Profitability
10
Growth
52
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALQGC.PA research report →
52-Week Range46% of range
Low
$0.00
Current
$0.07
High
$0.15
Company Overviewwww.quantum-genomics.com
About the company
Quantum Genomics S. A. , a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments.
- CEO
- Mathieu Bigois
- IPO
- 2010
- Employees
- 3
- HQ
- Paris, FR
Price Chart
-27.90% · this period
Valuation
- Market Cap
- $5.00M
- P/E
- -0.55
- P/S
- 499945.80
- P/B
- -2.05
- EV/EBITDA
- -4.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -11453070.00%
- Op Margin
- -14728350.00%
- Net Margin
- -88926030.00%
- ROE
- 880.77%
- ROIC
- -153.05%
Growth & Income
- Revenue
- $10 · -99.95%
- Net Income
- $-8,892,603 · -180.44%
- EPS
- $-0.13 · -42.86%
- Op Income
- $-1,472,835
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.15
- 52W Low
- $0.00
- 50D MA
- $0.07
- 200D MA
- $0.08
- Beta
- 0.16
- Avg Volume
- 0
Get TickerSpark's AI analysis on ALQGC.PA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · ALQGC.PA
Our ALQGC.PA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on ALQGC.PA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ALQGC.PA report →Internal Compare
Similar companies
Peers in the same neighborhood.